Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure.

Sanchez-Serna J, Martinez-Villanueva M, Hernández-Vicente Á, Asensio-Lopez MC, Noguera JA, Pascual-Figal DA.

Rev Clin Esp. 2019 Feb 5. pii: S0014-2565(18)30307-2. doi: 10.1016/j.rce.2018.10.004. [Epub ahead of print] English, Spanish.

PMID:
30737010
2.

Pulmonary Production of Soluble ST2 in Heart Failure.

Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A.

Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488.

PMID:
30562096
3.

Lack of improvement in autonomic cardiac tone after sacubitril/valsartan at lower than target doses.

Pastor-Pérez FJ, García-Alberola A, Navarro-Peñalver M, Goya-Esteban R, Garrido-Bravo IP, Barquero-Pérez O, Rojo-Álvarez JL, Pascual-Figal DA.

J Electrocardiol. 2019 Jan - Feb;52:99-100. doi: 10.1016/j.jelectrocard.2018.11.015. Epub 2018 Nov 28.

PMID:
30529813
4.

Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.

Caro Martínez C, Elvira Ruiz G, Flores Blanco PJ, Cerezo Manchado JJ, Albendín Iglesias H, Lova Navarro A, Arregui Montoya F, García Alberola A, Pascual Figal DA, Bailén Lorenzo JL, Manzano Fernández S.

Rev Esp Cardiol (Engl Ed). 2018 Nov 26. pii: S1885-5857(18)30436-5. doi: 10.1016/j.rec.2018.08.026. [Epub ahead of print] English, Spanish.

PMID:
30497945
5.

Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival.

Fernández-Gassó L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Hernández-Vicente Á, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 Sep 24. pii: S1885-5857(18)30367-0. doi: 10.1016/j.rec.2018.08.014. [Epub ahead of print] English, Spanish.

PMID:
30262426
6.

Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction.

Pérez-Martínez MT, Lacunza-Ruiz J, García de Lara J, Noguera-Velasco JA, Lax A, Hernández-Vicente Á, Asensio-López MC, Januzzi JL Jr, Ibañez B, Pascual-Figal DA.

J Am Coll Cardiol. 2018 Sep 18;72(12):1429-1430. doi: 10.1016/j.jacc.2018.06.062. No abstract available.

PMID:
30213338
7.

Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.

Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA.

J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):543-550. doi: 10.1177/1074248418784020. Epub 2018 Jun 21.

PMID:
29929385
8.

Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population.

Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hernández-Vicente Á, Reyes-Marle R, Castellón Sánchez MI, Claver-Valderas MA, Gonzalez-Vioque E, Haro-Del Moral FJ, García-Pavía P, Pascual-Figal DA.

Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006. Epub 2018 Jun 6.

PMID:
29903517
9.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal DA, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E, Bardaji A, Manito N, López-Garrido MA, Padron-Barthe L, Edwards E, Whiffin N, Walsh R, Buchan RJ, Midwinter W, Wilk A, Prasad S, Pantazis A, Baski J, O'Regan DP, Alonso-Pulpon L, Cook SA, Lara-Pezzi E, Barton PJ, Garcia-Pavia P.

J Am Coll Cardiol. 2018 May 22;71(20):2293-2302. doi: 10.1016/j.jacc.2018.03.462.

10.

Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.

Asensio-Lopez MDC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Pascual-Figal DA.

Transl Res. 2018 Sep;199:4-23. doi: 10.1016/j.trsl.2018.04.004. Epub 2018 Apr 23.

PMID:
29753686
11.

Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-defibrillator in Primary Prevention.

Navarro-Peñalver M, Mohamed-Salem L, Domínguez F, de Haro-Del Moral FJ, Fernández-Lozano I, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):180-182. doi: 10.1016/j.rec.2018.01.014. Epub 2018 Apr 9. English, Spanish. No abstract available.

PMID:
29650449
12.

Analysis of Hospitalization Trends for Heart Failure in the Health Registries of Different Autonomous Communities.

Fernández Gassó ML, Hernando-Arizaleta L, Palomar Rodríguez JA, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):128-129. doi: 10.1016/j.rec.2017.09.005. Epub 2017 Nov 27. English, Spanish. No abstract available.

PMID:
29191781
13.

Neprilysin and Heart Failure: A "Sympathetic" Relationship?

Pascual-Figal DA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2154-2156. doi: 10.1016/j.jacc.2017.09.003. No abstract available.

14.

Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data.

Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Pascual-Figal DA.

Int J Cardiol. 2017 Dec 1;248:246-251. doi: 10.1016/j.ijcard.2017.07.094. Epub 2017 Aug 4.

PMID:
28801153
15.

Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction.

Sanchez-Mas J, Lax A, Asensio-Lopez MC, Lencina M, Fernandez-Del Palacio MJ, Soriano-Filiu A, de Boer RA, Pascual-Figal DA.

J Cardiovasc Transl Res. 2017 Dec;10(5-6):460-469. doi: 10.1007/s12265-017-9761-1. Epub 2017 Jul 17.

PMID:
28718055
16.

Acute heart failure and biomarkers: time also matters, don't relax.

Pascual-Figal DA.

Eur J Heart Fail. 2017 Aug;19(8):1011-1013. doi: 10.1002/ejhf.880. Epub 2017 May 25. No abstract available.

17.

Short-term Serial Measurement of Galectin-3 in Hospitalized Patients With Acute Heart Failure.

Sánchez-Serna J, Pérez-Martínez MT, Asensio-López MC, Casas T, Noguera JA, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2018 May;71(5):401-402. doi: 10.1016/j.rec.2017.03.013. Epub 2017 May 1. English, Spanish. No abstract available.

PMID:
28473265
18.

Trends and Characteristics of Hospitalization for Heart Failure in a Population Setting From 2003 to 2013.

Fernández Gassó ML, Hernando-Arizaleta L, Palomar-Rodríguez JA, Soria-Arcos F, Pascual-Figal DA.

Rev Esp Cardiol (Engl Ed). 2017 Sep;70(9):720-726. doi: 10.1016/j.rec.2017.03.001. Epub 2017 Mar 28. English, Spanish.

PMID:
28363708
19.

Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.

Pascual-Figal DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, Delgado-Jimenez J, Alvarez-Garcia J, Gimeno-Blanes JR, Worner-Diz F, Bardají A, Alonso-Pulpon L, Gonzalez-Juanatey JR, Cinca J; MUSIC and REDINSCOR I research groups.

Int J Cardiol. 2017 Aug 1;240:265-270. doi: 10.1016/j.ijcard.2017.03.032. Epub 2017 Mar 9.

PMID:
28318662
20.

Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.

Aimo A, Vergaro G, Ripoli A, Bayes-Genis A, Pascual Figal DA, de Boer RA, Lassus J, Mebazaa A, Gayat E, Breidthardt T, Sabti Z, Mueller C, Brunner-La Rocca HP, Tang WH, Grodin JL, Zhang Y, Bettencourt P, Maisel AS, Passino C, Januzzi JL, Emdin M.

JACC Heart Fail. 2017 Apr;5(4):287-296. doi: 10.1016/j.jchf.2016.12.016. Epub 2017 Feb 8.

Supplemental Content

Loading ...
Support Center